Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study

This multicentre, randomised, double-blind, placebo-controlled, two-period crossover study assessed the effect of umeclidinium/vilanterol (UMEC/VI) on exercise capacity in patients with chronic obstructive pulmonary disease (COPD) using the endurance shuttle walk test (ESWT). Patients were randomise...

Descripción completa

Detalles Bibliográficos
Autores principales: Riley, John H., Kalberg, Chris J., Donald, Alison, Lipson, David A., Shoaib, Muhammad, Tombs, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755681/
https://www.ncbi.nlm.nih.gov/pubmed/29322050
http://dx.doi.org/10.1183/23120541.00073-2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755681/
https://www.ncbi.nlm.nih.gov/pubmed/29322050
http://dx.doi.org/10.1183/23120541.00073-2017

Ejemplares similares